Metformin in Differentiated Thyroid Cancer: Molecular Pathways and Its Clinical Implications

Metformin is a synthetic biguanide that improves insulin sensitivity and reduces hepatic gluconeogenesis. Aside being the first-line therapy for Type 2 Diabetes (T2D), many pleiotropic effects have been discovered in recent years, such as its capacity to reduce cancer risk and tumorigenesis. Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Sáenz, Manuel, Lobaton-Ginsberg, Miry, Ferreira-Hermosillo, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029304/
https://www.ncbi.nlm.nih.gov/pubmed/35454163
http://dx.doi.org/10.3390/biom12040574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029304/
https://www.ncbi.nlm.nih.gov/pubmed/35454163
http://dx.doi.org/10.3390/biom12040574

Ejemplares similares